Fastest Growing Healthcare & Life Science Companies in Europe in 2026

Europe’s healthcare sector is undergoing rapid transformations, fueled by digital innovation, decentralized care and shifting patient expectations. 

The latest FT1000: Europe’s Fastest-Growing Companies 2026 ranking, compiled by the Financial Times in partnership with Statista, highlights companies across sectors, including healthcare and life sciences, achieving exceptional revenue growth between 2021 and 2024 accompanied by increases in employee numbers and notable strategic acquisitions and partnerships.

Within this list, the Health Care & Life Sciences category reflects a highly growing sector being shaped by AI, digital platforms, home-based care and specialized therapeutics. Below we outline 11 of the fastest growing healthcare & life science companies in Europe in 2026, highlighting the innovations, business models and growth strategies driving their rapid expansion across the region.

1. WandelWerker Consulting (Germany)

WandelWerker is a consulting firm that helps companies improve workplace safety by transforming their organizational culture, processes and employee behavior. It works with businesses to develop long-term strategies that reduce workplace accidents and embed safety as a core part of how the organization operates. The company went from one employee in 2021 to 19 in 2024, with tremendous growth in revenues over the three-year period, going from €188,000 in 2021 to €2.04 million in 2024 at a striking compound annual growth rate (CAGR) of 124.8%.

2. Tepsivo (Finland)

Tepsivo is a Finland-based healthcare technology company that provides digital pharmacovigilance (PV) services, helping pharmaceutical and biotech companies monitor drug safety, manage adverse event reporting and stay compliant with global regulations. Founded in 2020, the company’s core offering is its proprietary Tepsivo OnePV platform, an end-to-end, AI-enabled system that centralizes all PV activities (from safety reporting to regulatory intelligence) into a single automated workflow, now used by 50+ pharma clients across more than 150 countries. In 2025, the company struck a partnership with, and minority investment from, Clinigen, a global pharma services provider. The partnership will support its expansion into broader international markets, combining Clinigen’s global infrastructure with Tepsivo’s AI-driven PV platform. Company sales grew from €333,000 in 2021 to €1.67 million in 2024 at a CAGR of 71.1%. Tepsivo has garnered recognition in other growth rankings, such as Deloitte’s Technology Fast 50 Finland (ranking 29 on the list). 

3. Camascope (UK)

UK-based Camascope is a health technology company that provides a digital medication management platform (eMAR) designed for care homes and community care providers. Its software replaces paper-based medication records with a real-time, cloud-based system that connects care staff, pharmacies and clinicians to help reduce medication errors, improve compliance and streamline workflows across more than 3,000 care organizations. Beyond core medication management, Camascope also offers remote patient monitoring and “virtual ward” solutions, enabling patients, particularly older adults, to be safely monitored at home while reducing hospital stays and easing pressure on healthcare systems. The company has gained traction through widespread NHS adoption, regulatory compliance (e.g., ISO27001, MHRA alignment) and integration with thousands of UK pharmacies and care systems. Company revenues climbed from €614,594 in 2021 to €2.91 million in 2024 at a CAGR of 67.1%. Camascope grew its employee headcount from 18 to 74 in the span of three years (2021 to 2024). 

4. Simple Online Pharmacy (UK)

Simple Online Pharmacy is a digital healthcare provider (part of Simple Online Healthcare) that offers a fully regulated online doctor service, private prescriptions and home-delivered medications, enabling patients to access treatment quickly and discreetly without visiting a physical clinic. Founded in 2015 in Glasgow, the company has scaled into a multi-market digital clinic platform operating across the UK, Germany, Australia and, more recently, Denmark, with a strong focus on high-demand areas like weight management and GLP-1 therapies. The company has expanded primarily through international market launches and selective acquisitions, including the 2022 purchase of Kapsel and Dr Felix from Stark Healthcare, which strengthened its presence in Germany and the UK. More recently, it reported rapid revenue growth, tripling to ~£66 million in 2025, and continued investment in technology, AI-enabled dispensing systems and digital patient platforms to scale operations. The company has gained recognition through programs like Tech Nation’s Future Fifty. Simple Online went from 52 employees to 132 in 2024.

5. Delft Imaging Systems (Netherlands)

Delft Imaging Systems is a Netherlands-based medical technology company that develops digital imaging solutions, particularly X-ray systems and AI-powered diagnostic tools, designed to improve healthcare access in low-resource and remote settings. Founded in 2002, the company operates as a social enterprise and certified B Corp, with its technologies (including mobile X-ray units and AI tools like CAD4TB for tuberculosis screening) deployed in more than 85 countries, often in partnership with global health organizations such as UN agencies and TB programs. In 2026, the company achieved ISO 13485 certification, reinforcing its compliance with international medical device standards and supporting further global deployment. It continues to expand through collaborations with public health organizations and governments, particularly in infectious disease screening and maternal health, and has gained recognition through awards and growth rankings in the Netherlands. The company saw massive revenue growth from 2021 to 2024, going from €7.54 million to €29.25 million in the three-year period at a CAGR of 57.1%. Employee numbers went from 14 to 29 in the same time frame.

Related: Top 5 Fastest Growing Pharma & Biotech Companies in Europe in 2026

6. Evondos (Finland)

Evondos is a health technology company that provides automated medication dispensing services for home care, using connected devices and cloud-based systems to ensure patients receive the right medicine at the right time while improving adherence and reducing caregiver workload. Its core solution combines an in-home dispensing robot with remote monitoring, helping healthcare providers deliver safer, more efficient care, particularly for elderly and chronically ill patients living independently. Evondos has grown significantly through strategic acquisitions and international expansion. Notably, the company acquired Dutch medication dispensing provider Medido in 2023, forming the broader Evondos Group and expanding its footprint across Europe. It has also invested in innovation through acquisitions such as camera-based vital signs monitoring technology Vitacam, strengthening its remote care capabilities. Backed by growth investor Verdane, Evondos is now expanding into new markets, including the UK (2025-2026), as demand for home-based care accelerates amid workforce shortages and aging populations. Company sales went from €16.63 million in 2021 to a whopping  €54.22 million in 2024 at a CAGR of 48.3%. And its workforce almost quadrupled from 119 to 457 in the same period.

7. Alcove Group (UK)

Alcove Group is a digital health and social care technology company that delivers an AI-powered, Internet of Things (IoT)-enabled “connected care” platform designed to help older and vulnerable people live independently at home. Its system integrates in-home sensors, wearables, video communication tools and a 24/7 monitoring service, allowing caregivers, families and health systems (including the NHS and local authorities) to track wellbeing, detect risks like falls and provide remote support in real time. Alcove has expanded primarily through public-sector partnerships and large-scale care contracts, positioning itself as a provider of county-wide technology-enabled care (TEC) services. Its platform now supports tens of thousands of users, with increasing adoption of features like virtual care delivery, remote monitoring and AI-driven alerts to reduce hospital admissions and improve outcomes. Company revenues increased from €3.5 million in 2021 to €9.08 million in 2024 at a CAGR of 36.8%, with a tripling of employee numbers from 32 to 101 in the three-year span.

8. Medinbox (France)

Medinbox is a healthtech company that develops integrated audiovisual and software systems for operating rooms and interventional labs, enabling hospitals to stream, record and share surgical procedures in real time. Its platform creates a “borderless” digital environment for live medical collaboration, remote proctoring, clinical education and expert consultation, allowing clinicians around the world to participate in procedures without being physically present. The system is designed to be hardware-light, cloud-enabled or on-premise, and fully controlled by medical teams, making it a flexible tool for modern “smart hospitals.” In recent years, Medinbox has expanded its global footprint to more than 100 countries and over 450 hospitals, supported by growing demand for remote surgical support and digital medical training. In 2024, the company completed a strategic funding round backed by investors including Arbevel, IRDI Capital Investissement and GSO Innovation, aimed at accelerating international expansion, particularly in the US, and advancing AI-driven capabilities within its platform. Medinbox has scaled through product innovation, hospital partnerships and investor-backed growth, positioning itself as a “Zoom for operating rooms” in the global medtech ecosystem. Company sales more than doubled from €2.15 million in 2021 to €4.66 million in 2024 at a CAGR of 29.5%, and grew from eight to 38 employees.

9. elderbrook solutions (Germany)

elderbrook solutions is a Germany-based contract research organization (CRO) and life sciences consultancy that supports pharmaceutical, biotech and medical device companies across the clinical development lifecycle. The company specializes in biostatistics, clinical data management, statistical programming, IT consulting, GxP compliance, validation and digital clinical solutions, helping sponsors design and run more efficient and data-driven clinical trials. Elderbrook has scaled into a mid-sized international CRO with around 200 experts across 20+ countries, expanding through both organic growth and acquisitions, including maxclinical GmbH, while also strengthening its capabilities in eClinical platforms and partnerships (e.g., Viedoc integration). It has also gained recognition in the industry through growth awards, CDISC membership, ISO-aligned quality systems and partnerships with global clinical technology providers, reflecting its positioning as a hybrid CRO and digital services provider rather than a traditional consultancy. Revenues grew from €6.48 million in 2021 to €13.28 million in 2024 at a CAGR of 27%, and grew from 33 to 48 employees in the same time frame.

10. Knights Pharmacy (UK)

Knights Pharmacy is an independent community pharmacy group that provides NHS and private healthcare services through a network of more than 70 pharmacies across England and Wales. Founded in 1984, it focuses on delivering accessible frontline care, including prescription dispensing, vaccinations, minor ailment services, health checks and specialist clinical services, through a combination of in-store and increasingly digital and extended clinical offerings. The company has expanded rapidly through a selective acquisition strategy backed by HSBC funding, including the purchase of multiple pharmacy groups in South Wales and the retention of local staff to maintain continuity of care. This expansion has helped it scale its footprint while strengthening its clinical service offering and digital infrastructure across its network. The company’s massive sales increased significantly, almost doubling, from €48.13 million in 2021 to €83.56 million in 2024 at a CAGR of 19.7%. Its employee headcount more than doubled from 200 to 500 during this period.

11. Eckert & Ziegler (Germany)

Eckert & Ziegler (EZAG) is an isotope technology and radiopharmaceutical manufacturing company specializing in the production of medical, scientific and industrial radioisotopes used in nuclear medicine, cancer diagnostics and targeted radiotherapy. The company operates across the full radiopharma value chain, from isotope production and radiopharmaceutical development to contract manufacturing (CMO services) and specialized lab equipment, making it one of the world’s largest suppliers of medical isotopes. In recent years, EZAG has significantly expanded its role in the fast-growing radiopharmaceuticals and theranostics market, driven by oncology innovation. It has formed multiple high-profile strategic partnerships with biotech companies such as Telix Pharmaceuticals, Bicycle Therapeutics, SK Biopharmaceuticals, Molecular Partners and others to supply isotopes like lutetium-177, actinium-225 and yttrium-90 for clinical trials and commercial development. The company has also increasingly positioned itself as a contract manufacturer for next-generation radiotherapeutics, supporting late-stage clinical programs and global supply chains. Eckert & Ziegler is a critical infrastructure player in nuclear medicine, acting as both a global isotope supplier and manufacturing partner for the rapidly expanding radiopharmaceutical oncology ecosystem. The company became a multi-hundred-million-dollar company in 2024, with company revenues growing from €180.44 million in 2021 to €295.85 million in 2024 at a CAGR of 17.9%. Its workforce also grew from 866 to 1,085 employees during the three-year time period.